WVE Wave Life Sciences Ltd. - Ordinary Shares
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 30, 2026
$3,78
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$3,5652 haftanın en düşüğü
$20,6352 haftanın en yükseği
Piyasa Değeri (MRQ)
$731M
P/E
-14.0
Hisse Başına Kâr
$-1.21
Gelir
$43M
rozetleriniz
52 Haftlık Aralık
$4–$21
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$19
P/E
-14.0
ROE
·
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
WVE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$3.78
Piyasa Değeri (MRQ)
$731M
P/E
-14.0
Hisse Başına Kâr
$-1.21
Gelir
$43M
52 Haftlık Aralık
$4–$21
WVE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Wave Life Sciences Ltd. - Ordinary Shares Hakkında Wikipedia'dan şirket genel bakışı
sektörHealthcare
endüstriPharmaceuticals
çalışanlar317
ülkeSG
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$43M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-1.212021-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | WVE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -14.05Y ort. ≈-9.2 | ≈-9.2 | · | · | |
| F/D (MRQ) | 1.6 | · | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -3.8 | · | · | · | |
| Fiyat / Nakit Akışı (TTM) | -3.8 | · | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 6.25Y ort. ≈9.0 | ≈9.0 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | WVE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 10.0 | · | · | · |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | WVE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -60.6%5Y ort. ≈590.6% | ≈590.6% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 127.1%5Y ort. ≈81.1% | ≈81.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 16.3% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | WVE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$134.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
3.3%
Sonraki Rapor
Kas 09, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 28, 2026 | $-0.34 | $-0.31 | -8.9% |
| 31 Mart 2026 | May 7, 2026 | $-0.13 | $-0.33 | 60.7% |
| 31 Aralık 2025 | $-0.30 | $-0.27 | -10.0% | |
| 30 Eylül 2025 | $-0.32 | $-0.30 | -6.2% | |
| 30 Haziran 2025 | $-0.31 | $-0.29 | -5.6% | |
| 31 Mart 2025 | $-0.29 | $-0.26 | -10.1% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| R&D Expense | $183M | $160M | $130M | $116M | $122M | $131M | $175M | $134M | $79M | $41M | $9M | |
| SG&A Expense | $75M | $59M | $51M | $51M | $46M | $43M | $49M | $40M | $27M | $16M | $10M | |
| Operating Expenses | $258M | $219M | $181M | $166M | $168M | $173M | $224M | $174M | $106M | $57M | $19M | |
| Operating Income | $-215M | $-110M | $-68M | $-163M | $-127M | $-153M | $-208M | $-160M | $-102M | $-56M | $-19M | |
| Other Non-op | $527.0K | $3M | $2M | $7.0K | $5M | $2M | $10M | $10M | $-331.0K | $-50.0K | $56.0K | |
| Pretax Income | $-204M | $-97M | $-58M | $-161M | $-122M | $-151M | $-194M | $-147M | $-101M | $-55M | $-19M | |
| Income Tax | $0 | $0 | $-677.0K | $681.0K | $-204.0K | $-841.0K | $0 | $69.0K | $842.0K | $482.0K | $44.0K | |
| Net Income | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| Shares (Basic) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · | |
| Shares (Diluted) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $602M | $302M | $200M | $88M | $151M | $184M | $147M | $175M | $143M | $150M | $161M | |
| Receivables | $1M | $1M | $21M | · | · | $30M | $20M | $10M | $1M | · | · | |
| Prepaid Expense | $8M | $10M | $10M | $8M | $7M | $10M | $10M | $7M | $7M | $1M | $146.0K | |
| Other Current Assets | $3M | $7M | $4M | $2M | $5M | $5M | $9M | $11M | · | · | · | |
| Current Assets | $615M | $320M | $235M | $99M | $163M | $230M | $185M | $202M | $150M | $152M | $161M | |
| PP&E (Net) | $7M | $10M | $13M | $17M | $22M | $29M | $36M | $40M | $27M | $9M | $3M | |
| PP&E (Gross) | $57M | $56M | $56M | $55M | $54M | $54M | $53M | $49M | $32M | $11M | $4M | |
| Accum. Depreciation | $50M | $46M | $43M | $38M | $32M | $25M | $17M | $10M | $4M | $2M | $2M | |
| Other Non-current Assets | $16.0K | $55.0K | $156.0K | · | · | · | · | · | · | · | · | |
| Total Assets | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Accounts Payable | $16M | $16M | $13M | $17M | $7M | $14M | $9M | $13M | $8M | $5M | $3M | |
| Accrued Liabilities | $7M | $5M | $2M | $4M | $4M | $2M | $5M | $6M | $3M | · | · | |
| Current Liabilities | $95M | $111M | $186M | $72M | $64M | $121M | $118M | $130M | $18M | $12M | $4M | |
| Capital Leases | $9M | $18M | $25M | $32M | $25M | $26M | $29M | · | · | $16.0K | $78.0K | |
| Other Non-current Liabilities | · | · | · | $190.0K | · | $474.0K | $2M | $2M | $2M | $796.0K | $163.0K | |
| Total Liabilities | $112M | $135M | $227M | $184M | $167M | $189M | $213M | $215M | $34M | $22M | $4M | |
| Common Stock | $1.62B | $1.18B | $935M | $803M | $750M | $694M | $540M | $375M | $310M | $216M | $185M | |
| Paid-in Capital | $228M | $156M | $129M | $119M | $88M | $72M | $57M | $38M | $22M | $10M | $3M | |
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967M | $-806M | $-683M | $-533M | $-340M | $-193M | $-90M | $-35M | |
| AOCI | $-250.0K | $-262.0K | $-124.0K | $-29.0K | $181.0K | $389.0K | $267.0K | $153.0K | $116.0K | $-291.0K | $41.0K | |
| Stockholders' Equity | $518M | $210M | $40M | $-45M | $32M | $83M | $64M | $73M | $140M | $135M | $153M | |
| Liabilities + Equity | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Shares Outstanding | 187,660,263 | 153,037,286 | 119,162,234 | 86,924,643 | 59,841,116 | 48,778,678 | 34,340,690 | 29,472,197 | 27,829,079 | 23,502,169 | 21,551,423 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $784.0K | $594.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $4M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | $908.0K | $-698.0K | $36.0K | |
| Operating Cash Flow | $-187M | $-151M | $-19M | $-128M | $-89M | $-116M | $-188M | $-23M | $-84M | $-32M | $-13M | |
| CapEx | $718.0K | $938.0K | $1M | $1M | $560.0K | $1M | $4M | $10M | $19M | $6M | $2M | |
| Investing Cash Flow | $-718.0K | $-938.0K | $-1M | $-1M | $-560.0K | $-1M | $-4M | $-10M | $-19M | $-6M | · | |
| Stock Issued | · | · | $94M | $51M | · | $94M | $162M | $60M | $94M | $30M | $12M | |
| Financing Cash Flow | $488M | $254M | $133M | $67M | $56M | $155M | $164M | $65M | $94M | $29M | · | |
| Net Change in Cash | $300M | $102M | $112M | $-62M | $-34M | $37M | $-28M | $32M | $-8M | $-8M | $160M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $-11.0K | $554.0K | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -60.6% | -4.4% | 3005.1% | -91.1% | 104.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 127.1% | 38.3% | 78.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| Net Income TTM | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| P/E | -14.0 | -17.7 | -9.4 | -3.4 | -1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 6.2 | 9.0 | 15.2 | · | 5.8 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -7.1% | -5.7% | -10.7% | -29.3% | -75.2% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | · | · | $9M | $9M | · | · | $20M | $13M | $49M | $22M | $13M | $285.0K | $375.0K | $2M | |
| R&D Expense | $51M | $47M | $53M | $46M | $43M | $41M | $45M | $41M | $40M | $33M | $32M | $33M | $31M | $28M | $30M | $27M | |
| SG&A Expense | $25M | $22M | $21M | $18M | $18M | $18M | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $12M | $13M | $12M | |
| Operating Expenses | $76M | $70M | $74M | $64M | $61M | $59M | $61M | $56M | $55M | $47M | $45M | $46M | $43M | $39M | $43M | $40M | |
| Operating Income | $-74M | $-31M | $-56M | $-56M | $-53M | $-50M | $23M | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M | |
| Interest Income | $5M | $5M | · | $2M | $2M | $3M | · | $2M | $2M | $3M | · | · | · | · | · | · | |
| Other Non-op | $-275.0K | $-80.0K | $234.0K | $324.0K | $-82.0K | $51.0K | $3M | $337.0K | $-18.0K | $365.0K | $171.0K | $118.0K | $1M | $-701.0K | $744.0K | $254.0K | |
| Pretax Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-677.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| EPS (Basic) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| EPS (Diluted) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| Shares (Basic) | 204,008,712 | 200,167,869 | · | 167,739,208 | 163,987,640 | 162,572,026 | · | 132,563,467 | 129,527,003 | 129,271,678 | 106,025,063 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| Shares (Diluted) | 204,008,712 | 200,167,869 | · | 167,739,208 | 163,987,640 | 162,572,026 | · | 132,563,467 | 129,527,003 | 129,271,678 | 106,975,231 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| EBITDA | · | $-31M | · | $-56M | $-53M | $-50M | · | $-64M | $-35M | · | $4M | $-23M | $-30M | $-39M | $-42M | $-38M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M | $154M | $181M | $140M | $173M | $208M | $97M | $123M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $25M | $50M | |
| Receivables | $888.0K | $0 | $1M | $10M | $2M | · | $1M | $0 | $1M | $0 | $7M | · | · | · | · | · | |
| Prepaid Expense | $12M | $13M | $8M | $7M | $7M | $8M | $10M | $11M | $12M | $11M | $8M | $9M | $9M | $7M | $5M | $7M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $7M | $7M | $7M | $3M | $5M | $5M | $4M | $3M | $3M | $2M | $7M | $6M | |
| Current Assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M | $172M | $197M | $159M | $185M | $220M | $131M | $160M | $124M | |
| PP&E (Net) | $7M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $12M | $14M | $15M | $16M | $19M | $20M | $21M | |
| PP&E (Gross) | · | · | $57M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $51M | $50M | $50M | $49M | $48M | $47M | $46M | $45M | $44M | $44M | $42M | $40M | $39M | · | · | · | |
| Other Non-current Assets | $667.0K | $386.0K | $16.0K | $22.0K | $728.0K | $448.0K | $55.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Accounts Payable | $20M | $19M | $16M | $14M | $15M | $14M | $16M | $13M | $18M | $12M | $13M | $12M | $12M | $16M | $11M | $10M | |
| Accrued Liabilities | $5M | $5M | $7M | $5M | $3M | $2M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Current Liabilities | $51M | $50M | $95M | $86M | $87M | $87M | $111M | $171M | $173M | $166M | $100M | $140M | $133M | $64M | $64M | $58M | |
| Capital Leases | $40M | $7M | $9M | $11M | $14M | $16M | $18M | $20M | $22M | $24M | $27M | $29M | $31M | $34M | $35M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $190.0K | $190.0K | · | · | $868.0K | |
| Total Liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M | $204M | $202M | $233M | $274M | $294M | $178M | $174M | $160M | |
| Common Stock | $1.63B | $1.63B | $1.62B | $1.22B | $1.19B | $1.18B | $1.18B | $1.14B | $951M | $950M | $841M | $840M | $838M | $803M | $802M | $751M | |
| Paid-in Capital | $248M | $237M | $228M | $174M | $168M | $161M | $156M | $153M | $136M | $132M | $127M | $125M | $122M | $117M | $113M | $92M | |
| Retained Earnings | $-1.42B | $-1.35B | $-1.33B | $-1.27B | $-1.22B | $-1.17B | $-1.12B | $-1.15B | $-1.09B | $-1.06B | $-1.01B | $-1.02B | $-995M | $-924M | $-885M | $-843M | |
| AOCI | $-172.0K | $-254.0K | $-250.0K | $-190.0K | $-161.0K | $-204.0K | $-262.0K | $-159.0K | $-279.0K | $-198.0K | $-182.0K | $-150.0K | $-50.0K | $-123.0K | $-47.0K | $95.0K | |
| Stockholders' Equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M | $-3M | $25M | $-40M | $-52M | $-35M | $-5M | $31M | $-53.0K | |
| Liabilities + Equity | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Shares Outstanding | 193,277,622 | 192,337,566 | 187,660,263 | 160,288,481 | 155,673,292 | 154,093,313 | 153,037,286 | 148,392,939 | 122,479,289 | 122,321,384 | 99,011,901 | 98,566,816 | 98,104,844 | 86,841,523 | 86,724,658 | 60,859,968 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-54M | $-60M | $-34M | $-45M | $-46M | $-63M | $-44M | $-46M | $-27M | $-33M | $-34M | $-37M | $86M | $-26M | $-29M | $-40M | |
| CapEx | $884.0K | $438.0K | $-1.0K | $248.0K | $306.0K | $165.0K | $86.0K | $383.0K | $52.0K | $417.0K | $198.0K | $72.0K | $489.0K | $457.0K | $492.0K | $208.0K | |
| Investing Cash Flow | $-123M | $-438.0K | $1.0K | $-248.0K | $-306.0K | $-165.0K | $-86.0K | $-383.0K | $-52.0K | $-417.0K | $-198.0K | $-72.0K | $-489.0K | $-501.0K | $25M | $-50M | |
| Stock Issued | · | · | · | · | · | · | · | $174M | $0 | $14M | $-35M | $-35M | $0 | $-229.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $35M | · | · | · | |
| Financing Cash Flow | $330.0K | $3M | $440M | $33M | $12M | $4M | $35M | $204M | $653.0K | $15M | $2M | $2M | $35M | $17.0K | $66M | $1M | |
| Net Change in Cash | $-177M | $-57M | $406M | $-12M | $-35M | $-59M | $-9M | $157M | $-27M | $-19M | $-33M | $-36M | $120M | $-26M | $61M | $-89M | |
| Free Cash Flow | · | $-60M | · | · | · | $-63M | · | · | · | · | · | · | $85M | · | · | $-40M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | · | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| Net Margin | · | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | · | 14.7% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| Pretax Margin | · | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | · | 13.4% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| EBITDA Margin | · | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | · | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| ROA | · | -6.0% | · | -17.9% | -21.9% | -17.9% | · | -22.1% | -15.0% | · | 3.8% | -9.5% | -12.6% | -20.4% | -19.7% | -18.4% | |
| ROE | · | -7.6% | · | -40.5% | -74.3% | -47.5% | · | -122.2% | 119.3% | · | -32.2% | 203.2% | 157.7% | -307.3% | -156.5% | -143.3% | |
| ROIC | · | -6.1% | · | -45.2% | -37.9% | -29.0% | · | -45.1% | 1006.5% | · | -12.1% | 45.4% | 87.2% | 860.8% | -136.2% | 71875.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.3 | · | 2.5 | 2.6 | 3.0 | · | 1.9 | 1.0 | · | 1.6 | 1.3 | 1.7 | 2.0 | 2.5 | 2.1 | |
| Quick Ratio | · | 10.9 | · | 2.4 | 2.4 | 2.8 | · | 1.8 | 0.9 | · | 1.5 | 1.2 | 1.6 | 1.9 | 2.3 | 1.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | · | · | 0.0 | 0.0 | · | · | 0.1 | · | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | 6.0 | · | · | · | 30.5 | · | 3.3 | · | · | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.66 | · | $0.78 | $0.89 | $1.11 | · | $0.95 | $-0.03 | · | $-0.41 | $-0.52 | $-0.35 | $-0.05 | $0.36 | $-0.00 | |
| Revenue / Share | · | $0.19 | · | · | $0.05 | $0.06 | · | · | $0.15 | · | $0.46 | $0.21 | $0.13 | $0.00 | $0.01 | · | |
| Cash Flow / Share | · | $-0.30 | · | · | · | $-0.39 | · | · | · | · | · | · | $0.84 | · | · | · | |
| Cash / Share | · | $2.83 | · | $1.22 | $1.34 | $1.58 | · | $2.10 | $1.26 | · | $1.41 | $1.75 | $2.12 | $1.12 | $1.42 | $1.01 | |
| EPS (TTM) | $-1.08 | $-1.05 | · | $-0.66 | $-0.81 | $-0.75 | · | $-1.10 | $-0.56 | $-0.51 | $-0.79 | $-1.28 | $-1.70 | $-2.27 | $-1.97 | $-2.13 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $110M | $110M | $113M | $85M | $37M | $15M | $4M | $40M | $43M | |
| Net Income TTM | $-202M | $-184M | · | $-122M | $-130M | $-112M | · | $-143M | $-73M | $-62M | $-85M | $-131M | $-151M | $-153M | $-120M | $-118M | |
| Market Cap | · | $1.39B | · | $1.17B | $1.01B | $1.25B | · | $1.22B | $611M | · | $569M | $359M | $425M | $313M | $282M | $122M | |
| P/E | -5.4 | -6.9 | · | -11.1 | -8.0 | -10.8 | · | -7.5 | -8.9 | -12.1 | -7.3 | -2.8 | -2.5 | -1.6 | -1.6 | -0.9 | |
| P/S | · | · | · | · | · | · | · | 11.0 | 5.5 | · | 6.7 | 9.8 | 28.6 | 75.1 | 7.0 | 2.8 | |
| P/B | · | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | -175.8 | · | -14.1 | -6.9 | -12.2 | -69.4 | 9.1 | -2296.6 | |
| P / Tangible Book | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | · | 29.7 | · | · | · | · | 9.1 | · | |
| P / Cash Flow | · | -23.4 | · | · | · | -19.8 | · | · | · | · | · | · | 5.0 | · | · | -3.1 | |
| Earnings Yield | -18.6% | -14.5% | · | -9.0% | -12.5% | -9.3% | · | -13.4% | -11.2% | -8.3% | -13.7% | -35.2% | -39.3% | -62.9% | -60.6% | -106.5% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $43M | $108M | $113M | $4M | $41M |
| Net Gelir | $-204M | $-97M | $-58M | $-162M | $-122M |
| Seyreltilmiş Hisse Başı Kâr | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 260 dosya · $1.1B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
260
Tutulan Değer
$1.1B
Yeni pozisyonlar
50
Çıkan pozisyonlar
39
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 50 (-7 önceki Ç'ye göre) | 39 (+3 önceki Ç'ye göre) | 99 (-14 önceki Ç'ye göre) | 59 (+5 önceki Ç'ye göre) | +5.4M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156.727.684 | 26.975.505 | 14,03% | Hisse senetleri |
| BlackRock, Inc. | $111.566.297 | 19.202.461 | 9,99% | Hisse senetleri |
| GSK plc | $106.007.465 | 18.245.691 | 9,49% | Hisse senetleri |
| VANGUARD GROUP INC | $60.753.682 | 3.573.746 | 5,44% | Hisse senetleri |
| MAVERICK CAPITAL LTD | $59.715.848 | 10.278.115 | 5,35% | Hisse senetleri |
| Driehaus Capital Management LLC | $31.624.661 | 5.443.143 | 2,83% | Hisse senetleri |
| PRIMECAP MANAGEMENT CO/CA/ | $31.110.354 | 5.354.622 | 2,79% | Hisse senetleri |
| 683 Capital Management, LLC | $28.759.500 | 4.950.000 | 2,57% | Hisse senetleri |
| FMR LLC | $28.599.589 | 4.922.477 | 2,56% | Hisse senetleri |
| STATE STREET CORP | $28.116.432 | 4.839.317 | 2,52% | Hisse senetleri |
| READYSTATE ASSET MANAGEMENT LP | $27.464.678 | 4.727.139 | 2,46% | Hisse senetleri |
| M28 Capital Management LP | $26.657.930 | 4.588.284 | 2,39% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $22.489.218 | 3.869.998 | 2,01% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $21.541.656 | 3.707.686 | 1,93% | Hisse senetleri |
| ALGERT GLOBAL LLC | $16.370.343 | 2.817.615 | 1,47% | Hisse senetleri |
| Qube Research & Technologies Ltd | $16.128.560 | 2.776.000 | 1,44% | Hisse senetleri |
| Squarepoint Ops LLC | $14.765.778 | 2.541.442 | 1,32% | Hisse senetleri |
| MORGAN STANLEY | $14.075.916 | 2.422.705 | 1,26% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.263.463 | 2.110.751 | 1,10% | Hisse senetleri |
| Pfizer Inc | $10.931.250 | 1.875.000 | 0,98% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $10.523.548 | 1.811.282 | 0,94% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $10.296.645 | 1.772.228 | 0,92% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.175.651 | 1.751.403 | 0,91% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9.920.932 | 1.746.643 | 0,89% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $9.920.137 | 1.707.809 | 0,89% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $9.903.261 | 1.704.520 | 0,89% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $9.575.141 | 1.648.045 | 0,86% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $9.425.807 | 1.622.342 | 0,84% | Hisse senetleri |
| Point72 Asset Management, L.P. | $8.627.786 | 1.484.989 | 0,77% | Hisse senetleri |
| FEDERATED HERMES, INC. | $8.518.820 | 1.466.234 | 0,76% | Hisse senetleri |
| RTW INVESTMENTS, LP | $7.843.500 | 1.350.000 | 0,70% | Hisse senetleri |
| NORTHERN TRUST CORP | $7.282.835 | 1.253.500 | 0,65% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.114.025 | 1.224.445 | 0,64% | Hisse senetleri |
| EMERALD ADVISERS, LLC | $7.111.237 | 1.223.965 | 0,64% | Hisse senetleri |
| MARSHALL WACE, LLP | $5.807.286 | 999.533 | 0,52% | Hisse senetleri |
| SymBiosis Capital Partners, LLC | $5.437.500 | 750.000 | 0,49% | Hisse senetleri |
| Pictet Asset Management Holding SA | $5.330.146 | 917.409 | 0,48% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $5.157.403 | 887.677 | 0,46% | Hisse senetleri |
| Aberdeen Group plc | $5.092.221 | 876.458 | 0,46% | Hisse senetleri |
| EMERALD MUTUAL FUND ADVISERS TRUST | $4.926.874 | 847.999 | 0,44% | Hisse senetleri |
| BAKER BROS. ADVISORS LP | $4.779.527 | 822.638 | 0,43% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $4.712.241 | 811.057 | 0,42% | Hisse senetleri |
| CAPITAL FUND MANAGEMENT S.A. | $4.268.874 | 734.746 | 0,38% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $3.708.360 | 638.272 | 0,33% | Hisse senetleri |
| JPMORGAN CHASE & CO | $3.546.519 | 618.172 | 0,32% | Hisse senetleri |
| Y-Intercept (Hong Kong) Ltd | $3.544.646 | 610.094 | 0,32% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $3.533.607 | 608.194 | 0,32% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $3.486.000 | 600.000 | 0,31% | Hisse senetleri |
| Walleye Capital LLC | $3.401.482 | 585.453 | 0,30% | Hisse senetleri |
| Nuveen, LLC | $3.191.328 | 549.282 | 0,29% | Hisse senetleri |
Aktivistler ve %5+ sahipler 4 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×9 başvurular | 11 Ağustos 2026 | 16,80% | Değişiklik | · | SEC |
| Shin Nippon Biomedical Laboratories, Ltd., SNBL USA, Ltd., Ken Takanashi ×6 başvurular | 12 Ağustos 2022 | · | İlk başvuru | · | SEC |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership, Kagoshima Development Co. Ltd. ×5 başvurular | 20 Temmuz 2022 | · | İlk başvuru | · | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×3 başvurular | 28 Ocak 2019 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 22 içeriden öğrenenler · 8 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Paul Bolno | President and CEO | 05 Şubat 2026 A | 275.520 | 0 | 1 | $-140.956 |
| Kyle Moran | Chief Financial Officer | 05 Şubat 2026 A | 134.385 | 0 | 7 | $-4.151.988 |
| David G Gaiero | Interim CFO | 03 Mart 2020 A | 6.392 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 07 Mart 2019 A | 29.186 | 0 | 0 | $0 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | 26 Şubat 2026 M | 61.867 | 0 | 14 | $-7.103.233 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | 05 Şubat 2026 A | 408.246 | 0 | 1 | $-43.417 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 25 Temmuz 2022 A | 109.103 | 0 | 0 | $0 |
| Mark Baldry | Chief Commerical Officer | 05 Ağustos 2019 A | 39.000 | 0 | 0 | $0 |
| Gregory L. Verdine | Yönetim kurulu üyesi | 08 Aralık 2025 S | 275.217 | 0 | 2 | $-269.461 |
| Christian O Henry | Yönetim kurulu üyesi | 08 Aralık 2025 M | 12.700 | 0 | 4 | $-1.369.324 |
| Mark Corrigan | Yönetim kurulu üyesi | 08 Aralık 2025 S | 28.815 | 0 | 2 | $-217.265 |
| Amy Pott | Yönetim kurulu üyesi | 18 Ağustos 2020 A | · | 0 | 0 | $0 |
| Peter Kolchinsky | Yönetim kurulu üyesi | 18 Ağustos 2020 A | · | 0 | 0 | $0 |
| Koji Miura | Yönetim kurulu üyesi | 15 Ağustos 2019 A | · | 0 | 0 | $0 |
| Masaharu Tanaka | Yönetim kurulu üyesi | 10 Kasım 2016 A | · | 0 | 0 | $0 |
| Takeshi Wada | Yönetim kurulu üyesi | 10 Kasım 2016 A | · | 0 | 0 | $0 |
| GSK plc | 10% sahip | 11 Aralık 2025 P | 18.245.691 | 1 | 0 | $27.930.000 |
| Adrian Rawcliffe | · | 12 Ağustos 2026 S | 0 | 0 | 3 | $-806.604 |
| Tan Aik Na | · | 11 Ağustos 2026 S | 24.968 | 0 | 9 | $-1.825.754 |
| Ken Takanashi | · | 11 Ağustos 2026 S | 20.079 | 0 | 1 | $-23.223 |
| Heidi L Wagner | · | 11 Ağustos 2026 M | 44.930 | 0 | 3 | $-231.070 |
| Roberto Guerciolini | · | 07 Aralık 2016 M | 4.000 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 30 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,11% | 41.500 NS | 31 Temmuz 2026 | N-PORT |
| IHE · iShares Trust | 0,16% | 562.937 SH | 11 Eylül 2026 | Günlük |
| IWC · iShares Trust | 0,15% | 470.896 SH | 11 Eylül 2026 | Günlük |
| IBB · iShares Trust | 0,06% | 1.217.594 SH | 11 Eylül 2026 | Günlük |
| NUSC · Nushares ETF Trust | 0,05% | 122.389 NS | 31 Temmuz 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 111.824 SH | 19 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 13.788 SH | 01 Ekim 2026 | Günlük |
| RSSL · Global X Funds | 0,02% | 66.050 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 3.532.850 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 793.588 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 386.104 NS | 31 Temmuz 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 88.704 SH | 01 Ekim 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.751.403 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 390.910 SH | 19 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,01% | 14.841 SH | 11 Eylül 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 7.302 SH | 11 Eylül 2026 | Günlük |
| DXUV · Dimensional ETF Trust | 0,00% | 4.263 NS | 31 Temmuz 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 19.243 NS | 31 Temmuz 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 88.152 SH | 11 Eylül 2026 | Günlük |
| DFAC · Dimensional ETF Trust | 0,00% | 195.202 NS | 31 Temmuz 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 64.397 SH | 10 Eylül 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,00% | 6.250 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 248.363 SH | 11 Eylül 2026 | Günlük |
| DFAU · Dimensional ETF Trust | 0,00% | 19.385 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 33.180 NS | 31 Temmuz 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.069 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.431 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 1.201.565 SH | 11 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 6.085 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 18.901 SH | 11 Eylül 2026 | Günlük |
WVE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 21 analist
AL
Medyan hedef
$15.00
+296,8%
7 33,3%
Güçlü Al
13 61,9%
Al
1 4,8%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
17 analist · 2026-09-28Ortalama hedef $18.53 +390,2%
← Tüm hedeflerin altında
Mevcut fiyat $3.78
Düşük$10.00
Ortalama$18.53
Yüksek$42.00
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Tem 30, 2026